Managing treatment-related uncertainties in proton beam radiotherapy for gastrointestinal cancersE. Tryggestad, Terence T. Sio, Wei Liu et al.|Journal of Gastrointestinal Oncology|2020Cited by 52
Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomesKrishan R. Jethwa, Christopher L. Hallemeier, E. Tryggestad et al.|Advances in Radiation Oncology|2018Cited by 29
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurélie Garant, Christopher L. Hallemeier, Jonathan B. Ashman et al.|Practical Radiation Oncology|2019Cited by 25
The emerging role of proton therapy for esophagus cancerKrishan R. Jethwa, Christopher L. Hallemeier, Michael G. Haddock et al.|Journal of Gastrointestinal Oncology|2020Cited by 17
Proton beam radiotherapy for esophagus cancer: state of the artKimberly R. Gergelis, Christopher L. Hallemeier, Krishan R. Jethwa et al.|Journal of Thoracic Disease|2020Cited by 13